NAS Healthy Babies Act

Bill: 114-s-2872
Sponsor: full_name: Sen. Capito, Shelley Moore [R-WV]
Introduced: 2016-04-28
Policy area: Health
Subjects: Child health

Congressional oversight

Drug trafficking and controlled substances

Drug, alcohol, tobacco use

Government studies and investigations

Health care costs and insurance

Medicaid
Latest action: action_date: 2016-04-28
text: Read twice and referred to the Committee on Finance.

Summaries:
action_date: 2016-04-28
action_desc: Introduced in Senate
text: <p><strong>Nurturing and Supporting Healthy Babies Act or the NAS Healthy Babies Act</strong></p> <p>This bill requires the Government Accountability Office (GAO) to report on neonatal abstinence syndrome (NAS), which results from a newborn's exposure to addictive opiate drugs while in the mother's womb.</p> <p>Specifically, the GAO shall report on:</p> <ul> <li>the prevalence of NAS, </li> <li>NAS treatment services for which coverage is available under state Medicaid programs, </li> <li>the settings and associated reimbursement methodologies for NAS treatment, </li> <li>the prevalence of utilization of various care settings under state Medicaid programs for NAS treatment, and </li> <li>any federal barriers to treating infants with NAS under state Medicaid programs.</li></ul> <p>The GAO shall also report on its recommendations for improvements that will ensure access to NAS treatment under state Medicaid programs.</p>

tv_txt: II 114th CONGRESS 2d Session S. 2872 IN THE SENATE OF THE UNITED STATES April 28, 2016 Mrs. Capito (for herself, Mr. Brown , and Mr. King ) introduced the following bill; which was read twice and referred to the Committee on Finance A BILL To require the Government Accountability Office to submit to Congress a report on neonatal abstinence syndrome (NAS) in the United States and its treatment under Medicaid.

1. Short title This Act may be cited as the Nurturing And Supporting Healthy Babies Act or as the NAS Healthy Babies Act . 2. GAO report on neonatal abstinence syndrome (NAS) (a) In general Not later than one year after the date of the enactment of this Act, the Comptroller General of the United States shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Finance and the Committee on Health, Education, Labor, and Pensions of the Senate a report on neonatal abstinence syndrome (in this section referred to as NAS ) in the United States. (b) Information To be included in report Such report shall include information on the following: (1) The prevalence of NAS in the United States, including the proportion of children born in the United States with NAS who are eligible for medical assistance under State Medicaid programs under title XIX of the Social Security Act at birth and the costs associated with NAS through such programs. (2) The services for which coverage is available under State Medicaid programs for treatment of infants with NAS. (3) The settings (including inpatient, outpatient, hospital-based, and other settings) for the treatment of infants with NAS and the reimbursement methodologies and costs associated with such treatment in such settings. (4) The prevalence of utilization of various care settings under State Medicaid programs for treatment of infants with NAS and any Federal barriers to treating such infants under such programs, particularly in nonhospital-based settings. (c) Recommendations Such report also shall include such recommendations as the Comptroller General determines appropriate for improvements that will ensure access to treatment for infants with NAS under State Medicaid programs.